Cargando…
Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line
The preparation of a manganese-doped cerium oxide (Mn:CeO(2)) nanocomposite via hydrothermal route is described. Cubic fluorite structure of single phase was exhibited by studying structural analysis through x-ray diffraction (XRD) technique and morphological analysis was conducted by scanning elect...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878823/ https://www.ncbi.nlm.nih.gov/pubmed/33613052 http://dx.doi.org/10.1016/j.sjbs.2020.12.006 |
_version_ | 1783650401638154240 |
---|---|
author | Atif, M. Iqbal, Seemab Fakhar-e-Alam, M. Mansoor, Qaisar Alimgeer, K.S. Fatehmulla, Amanullah Hanif, Atif Yaqub, Nafeesah Farooq, W.A. Ahmad, Shafiq Ahmad, Hijaz Chu, Yu-ming |
author_facet | Atif, M. Iqbal, Seemab Fakhar-e-Alam, M. Mansoor, Qaisar Alimgeer, K.S. Fatehmulla, Amanullah Hanif, Atif Yaqub, Nafeesah Farooq, W.A. Ahmad, Shafiq Ahmad, Hijaz Chu, Yu-ming |
author_sort | Atif, M. |
collection | PubMed |
description | The preparation of a manganese-doped cerium oxide (Mn:CeO(2)) nanocomposite via hydrothermal route is described. Cubic fluorite structure of single phase was exhibited by studying structural analysis through x-ray diffraction (XRD) technique and morphological analysis was conducted by scanning electron microscope. Surface analytic technique of energy dispersive x-ray spectroscopy (EDX) was conducted to analyze the relative amount of any impurity and doping. Structural changes due to manganese doping such as increment in production of vacancies of oxygen within crystal of cerium oxide, and reduction in size of crystallite and constant of lattice was observed in our research study. Moreover, the Mn:CeO(2) nanocomposite demonstrates differential cytotoxicity against MCF-7 adenocarcinoma cell line, which renders it a promising candidate for targeted cancer therapy. The anti-tumorous activity of the cerium oxide nanocomposite was significantly enhanced with doping of manganese, which is directly linked with the generation of highly reactive oxygen facets. The experimental results are supported by a mathematical model that confirms a confidence level of 95%. This research has paved the way for many utilities in therapeutics and magnetic resonance imaging diagnostics through new observations, and hence verified their math model. |
format | Online Article Text |
id | pubmed-7878823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-78788232021-02-18 Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line Atif, M. Iqbal, Seemab Fakhar-e-Alam, M. Mansoor, Qaisar Alimgeer, K.S. Fatehmulla, Amanullah Hanif, Atif Yaqub, Nafeesah Farooq, W.A. Ahmad, Shafiq Ahmad, Hijaz Chu, Yu-ming Saudi J Biol Sci Original Article The preparation of a manganese-doped cerium oxide (Mn:CeO(2)) nanocomposite via hydrothermal route is described. Cubic fluorite structure of single phase was exhibited by studying structural analysis through x-ray diffraction (XRD) technique and morphological analysis was conducted by scanning electron microscope. Surface analytic technique of energy dispersive x-ray spectroscopy (EDX) was conducted to analyze the relative amount of any impurity and doping. Structural changes due to manganese doping such as increment in production of vacancies of oxygen within crystal of cerium oxide, and reduction in size of crystallite and constant of lattice was observed in our research study. Moreover, the Mn:CeO(2) nanocomposite demonstrates differential cytotoxicity against MCF-7 adenocarcinoma cell line, which renders it a promising candidate for targeted cancer therapy. The anti-tumorous activity of the cerium oxide nanocomposite was significantly enhanced with doping of manganese, which is directly linked with the generation of highly reactive oxygen facets. The experimental results are supported by a mathematical model that confirms a confidence level of 95%. This research has paved the way for many utilities in therapeutics and magnetic resonance imaging diagnostics through new observations, and hence verified their math model. Elsevier 2021-02 2020-12-11 /pmc/articles/PMC7878823/ /pubmed/33613052 http://dx.doi.org/10.1016/j.sjbs.2020.12.006 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Atif, M. Iqbal, Seemab Fakhar-e-Alam, M. Mansoor, Qaisar Alimgeer, K.S. Fatehmulla, Amanullah Hanif, Atif Yaqub, Nafeesah Farooq, W.A. Ahmad, Shafiq Ahmad, Hijaz Chu, Yu-ming Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line |
title | Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line |
title_full | Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line |
title_fullStr | Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line |
title_full_unstemmed | Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line |
title_short | Manganese-doped cerium oxide nanocomposite as a therapeutic agent for MCF-7 adenocarcinoma cell line |
title_sort | manganese-doped cerium oxide nanocomposite as a therapeutic agent for mcf-7 adenocarcinoma cell line |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878823/ https://www.ncbi.nlm.nih.gov/pubmed/33613052 http://dx.doi.org/10.1016/j.sjbs.2020.12.006 |
work_keys_str_mv | AT atifm manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT iqbalseemab manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT fakharealamm manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT mansoorqaisar manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT alimgeerks manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT fatehmullaamanullah manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT hanifatif manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT yaqubnafeesah manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT farooqwa manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT ahmadshafiq manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT ahmadhijaz manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline AT chuyuming manganesedopedceriumoxidenanocompositeasatherapeuticagentformcf7adenocarcinomacellline |